文献速递肝病消化道肿瘤与早癌

TREM-2通过多因素保护机制防御肝细胞癌

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
PubMed 文献 · Gut · 2020-09-09

本文研究TREM-2在肝再生和肝细胞癌发生中的作用。TREM-2在人肝细胞癌组织、小鼠肝再生和肝细胞癌模型中表达上调;Trem-2-/-小鼠在二乙基亚硝胺(DEN)处理后发生更多肝肿瘤,并表现出加重的肝损伤、炎症、氧化应激和肝细胞增殖;抗氧化饮食可阻断两种基因型小鼠中DEN诱导的肝癌发生;在纤维化相关肝细胞癌模型中Trem-2-/-动物发生更多和更大的肿瘤;部分肝切除后Trem-2-/-肝脏显示肝细胞增殖和炎症增加;过表达TREM-2的人肝星状细胞条件培养基通过减弱Wnt配体分泌在体外抑制人肝细胞癌球体生长。结论认为TREM-2通过不同多效作用在肝癌发生中发挥保护作用,提示应研究TREM-2激动剂。

要点

  • TREM-2在人肝细胞癌组织、小鼠肝再生和肝细胞癌模型中表达上调。
  • Trem-2-/-小鼠在DEN处理后发生更多肝肿瘤,并显示加重的肝损伤、炎症、氧化应激和肝细胞增殖。
  • 过表达TREM-2的人肝星状细胞条件培养基通过减弱Wnt配体分泌在体外抑制人肝细胞癌球体生长。

核心结论

  • TREM-2通过不同多效作用在肝癌发生中发挥保护作用,提示应研究TREM-2激动剂,因其可能以多因素方式有益影响肝细胞癌发病机制。

研究设计与样本

  • 分析两个独立肝细胞癌患者队列的肝组织与对照肝样本中TREM-2表达。
  • 在野生型和Trem-2-/-小鼠中进行实验性肝细胞癌和肝再生模型,并进行肝星状细胞和肝细胞癌球体的体外研究。

主要发现

  • TREM-2表达在人肝细胞癌组织、小鼠肝再生和肝细胞癌模型中上调。
  • Trem-2-/-小鼠在DEN处理后发生更多肝肿瘤(不论大小),并显示加重的肝损伤、炎症、氧化应激和肝细胞增殖。
  • 给予抗氧化饮食阻断了两种基因型中DEN诱导的肝癌发生。
  • 在纤维化相关肝细胞癌模型中Trem-2-/-动物发生更多和更大的肿瘤。
  • 部分肝切除后Trem-2-/-肝脏显示肝细胞增殖和炎症增加;过表达TREM-2的人肝星状细胞条件培养基通过减弱Wnt配体分泌在体外抑制人肝细胞癌球体生长。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer usually arising on a background of chronic liver injury involving inflammatory and hepatic regenerative processes. The triggering receptor expressed on myeloid cells 2 (TREM-2) is predominantly expressed in hepatic non-parenchymal cells and inhibits Toll-like receptor signalling, protecting the liver from various hepatotoxic injuries, yet its role in liver cancer is poorly defined. Here, we investigated the impact of TREM-2 on liver regeneration and hepatocarcinogenesis. DESIGN: TREM-2 expression was analysed in liver tissues of two independent cohorts of patients with HCC and compared with control liver samples. Experimental HCC and liver regeneration models in wild type and Trem-2-/- mice, and in vitro studies with hepatic stellate cells (HSCs) and HCC spheroids were conducted. RESULTS: TREM-2 expression was upregulated in human HCC tissue, in mouse models of liver regeneration and HCC. Trem-2-/- mice developed more liver tumours irrespective of size after diethylnitrosamine (DEN) administration, displayed exacerbated liver damage, inflammation, oxidative stress and hepatocyte proliferation. Administering an antioxidant diet blocked DEN-induced hepatocarcinogenesis in both genotypes. Similarly, Trem-2-/- animals developed more and larger tumours in fibrosis-associated HCC models. Trem-2-/- livers showed increased hepatocyte proliferation and inflammation after partial hepatectomy. Conditioned media from human HSCs overexpressing TREM-2 inhibited human HCC spheroid growth in vitro through attenuated Wnt ligand secretion. CONCLUSION: TREM-2 plays a protective role in hepatocarcinogenesis via different pleiotropic effects, suggesting that TREM-2 agonism should be investigated as it might beneficially impact HCC pathogenesis in a multifactorial manner.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Esparza-Baquer A, Labiano I, Sharif O, et al. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms. Gut. 2020. PMID: 32907830. doi:10.1136/gutjnl-2019-319227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。